International Stem Cell Corp (ISCO) is a biotechnology company listed on US.
Latest reported ISCO revenue for 2026-06-30 was $5.0M. Net income was -$291.0K. ISCO currently screens at market cap $880.5K.
Use this ISCO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ISCO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ISCO SEC filings page. Lician reads the product cache first so this HTML stays unique to International Stem Cell Corp even when a live quote feed is slow.
Latest cached year on this hub. Full ISCO income, balance, and cash tables.